Table 1 Baseline patient characteristics
Characteristics | All patients 23 (100)a | NR 7 (30) | PR 10 (43) | TR 6 (26) | p valueb |
|---|---|---|---|---|---|
Age (years) | |||||
Median | 58.6 ± 11.1 | 54.7 ± 14.3 | 59.7 ± 10.2 | 61.3 ± 8.6 | |
Range | 31–75 | 31–72 | 47–75 | 48–71 | |
Sex | 0.324 | ||||
Male | 19 (83) | 7 (100) | 7 (70) | 5 (83) | |
Female | 4 (17) | 0 | 3 (30) | 1 (17) | |
Tumor location from anal verge (cm) | 0.961 | ||||
3–5 | 10 (43) | 3 (43) | 5 (50) | 2 (33) | |
6–10 | 11 (48) | 3 (43) | 4 (40) | 4 (67) | |
> 10 | 2 (9) | 1 (14) | 1 (10) | 0 | |
Tumor differentiation | 0.884 | ||||
Missing value | 9 (39) | 3 (43) | 3 (30) | 3 (50) | |
Well | 5 (22) | 2 (29) | 2 (20) | 1 (17) | |
Moderately | 9 (39) | 2 (29) | 5 (50) | 2 (33) | |
Undifferentiated | 0 | 0 | 0 | 0 | |
Pre-treatment stage | 0.441 | ||||
IIA | 3 (13) | 0 | 2 (20) | 1 (17) | |
IIIA | 1 (4) | 0 | 1 (10) | 0 | |
IIIA–IIIB | 2 (9) | 0 | 0 | 2 (33) | |
IIIB | 4 (17) | 1 (14) | 2 (20) | 1 (17) | |
IIIB–IIIC | 12 (52) | 5 (71) | 5 (50) | 2 (33) | |
IIIC | 1 (4) | 1 (14) | 0 | 0 | |
iT | 0.560 | ||||
T2 | 3 (13) | 0 | 1 (10) | 2 (33) | |
T3 | 18 (78) | 6 (86) | 8 (80) | 4 (67) | |
T4 | 2 (9) | 1 (14) | 1 (10) | 0 |